This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral molecules. Its structure, featuring an amino group and a methoxyphenyl moiety, makes it a valuable intermediate in the production of active pharmaceutical ingredients (APIs) that target neurological and psychiatric disorders. It is often employed in the creation of compounds that interact with neurotransmitter systems, such as serotonin and dopamine receptors, due to its potential to modulate these pathways. Additionally, its chiral nature allows for the development of enantiomerically pure drugs, enhancing efficacy and reducing side effects in therapeutic applications. Researchers also explore its use in asymmetric synthesis, where it serves as a building block for complex organic molecules with high stereochemical precision.